Resources

  VBLOC® – Vagal Blocking Therapy for Weight Reduction  VBLOC® is a first-in-class weight loss treatment designed to treat a range of gastrointestinal and metabolic diseases. Delivered by a pacemaker-like device called the Maestro® Rechargeable System,VBLOC Therapy is designed to block vagal nerve signaling between the brain and stomach believed to …

According to multiple presentations, IDegLira, the fixed combination of insulin degludec and liraglutide, showed long-term efficacy across a range of body mass indices and parameters for type 2 diabetes patients…. 

Consuming healthier foods improves risk independently of other lifestyle changes such as weight loss or physical activity…. 

Results from dulaglutide’s sixth AWARD trial showed once-weekly dulaglutide 1.5mg was non-inferior to once-daily liraglutide 1.8mg when compared to metformin…. 

A large database analysis has found that two oral diabetes drug classes, thiazolidinediones (TZDs) and sulfonylureas, both increase the risk for fractures when compared with metformin…. 

Diabetic patients who received bariatric surgery saw greater weight loss and fewer macrovascular and microvascular complications than those treated with usual care…. 

The United States has 3 million more diabetic patients today than in 2010…. 

The FDA recently approved tapentadol-ER (Nucynta ER) for the treatment of peripheral neuropathy in diabetics…. 

HNF1A is also the gene responsible for (maturity onset diabetes of the young type 3 (MODY3), a rare monogenic cause of diabetes….

Type 1 diabetes patients have better control of their blood sugar levels with an artificial pancreas….